Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 28, 2016 02:30 ET | Source: Immune Pharmaceuticals Inc

NEW DATA SUGGESTS IMPROVED TUMOR RESPONSE FOR THE COMBINATION OF AZIXA® AND IMMUNE CHECKPOINT INHIBITORS IN THE TREATMENT OF CANCER

NEW DATA SUGGESTS IMPROVED TUMOR RESPONSE FOR THE COMBINATION OF AZIXA AND IMMUNE CHECKPOINT INHIBITORS IN THE TREATMENT OF CANCER Immune Pharmaceuticals Files New Provisional Patent...
November 26, 2013 00:38 ET | Source: Immune Pharmaceuticals Inc

Immune Pharmaceuticals' Common Stock Approved for Trading on NASDAQ OMX First North Premier

TARRYTOWN, N.Y. and HERZLIYA-PITUACH, Israel, Nov. 26, 2013 /PRNewswire/ -- Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX Stockholm Exchange: IMNP) announced today that its common stock has...
November 20, 2013 03:14 ET | Source: Immune Pharmaceuticals Inc

Immune Pharmaceuticals Reports Third Quarter 2013 Financial Results

GAIN ON MERGER TRANSACTION DRIVES INCREASE IN STOCKHOLDERS' EQUITY TO $7.8 MILLION TARRYTOWN, N.Y. and HERZLIYA-PITUACH, Israel, Nov. 20, 2013 /PRNewswire/ -- Immune Pharmaceuticals...
November 01, 2013 02:08 ET | Source: Immune Pharmaceuticals Inc

Immune Pharmaceuticals Appoints Liquidity Provider to Facilitate Trading on NASDAQ OMX Stockholm Exchange

TARRYTOWN, N.Y. and HERZLIYA-PITUACH, Israel, Nov. 1, 2013 -- Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX Stockholm Exchange: IMNP) announced today that it has appointed Erik Penser...
October 16, 2013 00:43 ET | Source: Immune Pharmaceuticals Inc

New Data Supports Clinical Rationale for Bertilimumab in Ulcerative Colitis

Phase II Trial to Focus on Moderate to Severe UC Patients with Eotaxin-1 Biomarker TARRYTOWN, N.Y. and HERZLIYA-PITUACH, Israel, Oct. 16, 2013 /PRNewswire/ -- Immune Pharmaceuticals...
October 15, 2013 01:04 ET | Source: Immune Pharmaceuticals Inc

Immune Pharmaceuticals Announces Changes to its Board of Directors

New Members Provide strong financing and operating experience TARRYTOWN, N.Y. and HERZLIYA-PITUACH, Israel, Oct. 15, 2013 /PRNewswire/ -- Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX...
October 03, 2013 00:37 ET | Source: Immune Pharmaceuticals Inc

IMMUNE Pharmaceuticals Inc. to Present at 12th Annual BIO Investor Forum

TARRYTOWN, N.Y., Oct. 3, 2013 /PRNewswire/ -- Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX Stockholm Exchange: IMNP) announced today that Dr. Daniel G. Teper, Company Chairman and CEO,...
September 30, 2013 03:16 ET | Source: Immune Pharmaceuticals Inc

Immune Pharmaceuticals Announces Focus on Capital Raising and Primary Listing in The United States

Company to Transfer Swedish Listing to NASDAQ OMX First North Premier TARRYTOWN, N.Y., Sept. 30, 2013 /PRNewswire/ -- Immune Pharmaceuticals Inc. (NASDAQ OMX Stockholm Exchange and OTCQX: IMNP)...
September 23, 2013 00:57 ET | Source: Immune Pharmaceuticals Inc

Immune Pharmaceuticals Inc. Trading Symbol is Now IMNP on Both NASDAQ OMX Stockholm Exchange and OTCQX Trading Platform

TARRYTOWN, N.Y., Sept. 23, 2013 /PRNewswire/ -- Immune Pharmaceuticals Inc. (NASDAQ OMX Stockholm Exchange: IMNP and OTCQX: IMNP, formerly EPCTD) announced today that effective September 23, 2013...
September 04, 2013 03:07 ET | Source: Immune Pharmaceuticals Inc

Immune Pharmaceuticals Inc. Presenting At The 15th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th, 2013

TARRYTOWN, N.Y., Sept. 4, 2013 /PRNewswire/ -- Immune Pharmaceuticals Inc. (NASDAQ OMX Stockholm Exchange: IMNP and OTCQX: EPCTD) today announced it will be featured as a presenting company at the...